Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

36 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Clinical and pathologic correlation of cutaneous COVID-19 vaccine reactions including V-REPP: A registry-based study.
McMahon DE, Kovarik CL, Damsky W, Rosenbach M, Lipoff JB, Tyagi A, Chamberlin G, Fathy R, Nazarian RM, Desai SR, Lim HW, Thiers BH, Hruza GJ, French LE, Blumenthal K, Fox LP, Freeman EE. McMahon DE, et al. Among authors: chamberlin g. J Am Acad Dermatol. 2022 Jan;86(1):113-121. doi: 10.1016/j.jaad.2021.09.002. Epub 2021 Sep 10. J Am Acad Dermatol. 2022. PMID: 34517079 Free PMC article.
Varicella-zoster and herpes simplex virus reactivation post-COVID-19 vaccination: a review of 40 cases in an International Dermatology Registry.
Fathy RA, McMahon DE, Lee C, Chamberlin GC, Rosenbach M, Lipoff JB, Tyagi A, Desai SR, French LE, Lim HW, Thiers BH, Hruza GJ, Fassett M, Fox LP, Greenberg HL, Blumenthal K, Freeman EE. Fathy RA, et al. Among authors: chamberlin gc. J Eur Acad Dermatol Venereol. 2022 Jan;36(1):e6-e9. doi: 10.1111/jdv.17646. Epub 2021 Oct 5. J Eur Acad Dermatol Venereol. 2022. PMID: 34487581 Free PMC article. No abstract available.
Dermatology COVID-19 Registries: Updates and Future Directions.
Freeman EE, Chamberlin GC, McMahon DE, Hruza GJ, Wall D, Meah N, Sinclair R, Balogh EA, Feldman SR, Lowes MA, Marzano AV, Naik HB, Castelo-Soccio L, Lara-Corrales I, Cordoro KM, Mahil SK, Griffiths CEM, Smith CH, Irvine AD, Spuls PI, Flohr C, French LE. Freeman EE, et al. Dermatol Clin. 2021 Oct;39(4):575-585. doi: 10.1016/j.det.2021.05.013. Epub 2021 May 31. Dermatol Clin. 2021. PMID: 34556247 Free PMC article. Review.
Duration of Shedding of Culturable Virus in SARS-CoV-2 Omicron (BA.1) Infection.
Boucau J, Marino C, Regan J, Uddin R, Choudhary MC, Flynn JP, Chen G, Stuckwisch AM, Mathews J, Liew MY, Singh A, Lipiner T, Kittilson A, Melberg M, Li Y, Gilbert RF, Reynolds Z, Iyer SL, Chamberlin GC, Vyas TD, Goldberg MB, Vyas JM, Li JZ, Lemieux JE, Siedner MJ, Barczak AK. Boucau J, et al. Among authors: chamberlin gc. N Engl J Med. 2022 Jul 21;387(3):275-277. doi: 10.1056/NEJMc2202092. Epub 2022 Jun 29. N Engl J Med. 2022. PMID: 35767428 Free PMC article. No abstract available.
Duration of viral shedding and culture positivity with postvaccination SARS-CoV-2 delta variant infections.
Siedner MJ, Boucau J, Gilbert RF, Uddin R, Luu J, Haneuse S, Vyas T, Reynolds Z, Iyer S, Chamberlin GC, Goldstein RH, North CM, Sacks CA, Regan J, Flynn JP, Choudhary MC, Vyas JM, Barczak AK, Lemieux JE, Li JZ. Siedner MJ, et al. JCI Insight. 2022 Jan 25;7(2):e155483. doi: 10.1172/jci.insight.155483. JCI Insight. 2022. PMID: 34871181 Free PMC article.
Duration of viable virus shedding in SARS-CoV-2 omicron variant infection.
Boucau J, Marino C, Regan J, Uddin R, Choudhary MC, Flynn JP, Chen G, Stuckwisch AM, Mathews J, Liew MY, Singh A, Lipiner T, Kittilson A, Melberg M, Li Y, Gilbert RF, Reynolds Z, Iyer SL, Chamberlin GC, Vyas TD, Goldberg MB, Vyas JM, Li JZ, Lemieux JE, Siedner MJ, Barczak AK. Boucau J, et al. Among authors: chamberlin gc. medRxiv [Preprint]. 2022 Mar 2:2022.03.01.22271582. doi: 10.1101/2022.03.01.22271582. medRxiv. 2022. Update in: N Engl J Med. 2022 Jul 21;387(3):275-277. doi: 10.1056/NEJMc2202092 PMID: 35262089 Free PMC article. Updated. Preprint.
Vaccine Breakthrough Infection with the SARS-CoV-2 Delta or Omicron (BA.1) Variant Leads to Distinct Profiles of Neutralizing Antibody Responses.
Seaman MS, Siedner MJ, Boucau J, Lavine CL, Ghantous F, Liew MY, Mathews J, Singh A, Marino C, Regan J, Uddin R, Choudhary MC, Flynn JP, Chen G, Stuckwisch AM, Lipiner T, Kittilson A, Melberg M, Gilbert RF, Reynolds Z, Iyer SL, Chamberlin GC, Vyas TD, Vyas JM, Goldberg MB, Luban J, Li JZ, Barczak AK, Lemieux JE. Seaman MS, et al. Among authors: chamberlin gc. medRxiv [Preprint]. 2022 Mar 3:2022.03.02.22271731. doi: 10.1101/2022.03.02.22271731. medRxiv. 2022. Update in: JCI Insight. 2022 Oct 10;7(19):e159944. doi: 10.1172/jci.insight.159944 PMID: 35262094 Free PMC article. Updated. Preprint.
Characterization of Virologic Rebound Following Nirmatrelvir-Ritonavir Treatment for Coronavirus Disease 2019 (COVID-19).
Boucau J, Uddin R, Marino C, Regan J, Flynn JP, Choudhary MC, Chen G, Stuckwisch AM, Mathews J, Liew MY, Singh A, Reynolds Z, Iyer SL, Chamberlin GC, Vyas TD, Vyas JM, Turbett SE, Li JZ, Lemieux JE, Barczak AK, Siedner MJ. Boucau J, et al. Among authors: chamberlin gc. Clin Infect Dis. 2023 Feb 8;76(3):e526-e529. doi: 10.1093/cid/ciac512. Clin Infect Dis. 2023. PMID: 35737946 Free PMC article.
Data Resource Profile: The Global Health and Population Project on Access to Care for Cardiometabolic Diseases (HPACC).
Manne-Goehler J, Theilmann M, Flood D, Marcus ME, Andall-Brereton G, Agoudavi K, Arboleda WAL, Aryal KK, Bicaba B, Bovet P, Brant LCC, Brian G, Chamberlin G, Chen G, Damasceno A, Dorobantu M, Dunn M, Ebert C, Farzadfar F, Gurung MS, Guwatudde D, Houehanou C, Houinato D, Hwalla N, Jorgensen JMA, Karki KB, Labadarios D, Lunet N, Malta DC, Martins JS, Mayige MT, McClure RW, Saeedi Moghaddam S, Mwangi KJ, Mwalim O, Norov B, Quesnel-Crooks S, Rhode S, Seiglie JA, Sibai A, Silver BK, Sturua L, Stokes A, Supiyev A, Tsabedze L, Zhumadilov Z, Jaacks LM, Atun R, Davies JI, Geldsetzer P, Vollmer S, Bärnighausen TW. Manne-Goehler J, et al. Among authors: chamberlin g. Int J Epidemiol. 2022 Dec 13;51(6):e337-e349. doi: 10.1093/ije/dyac125. Int J Epidemiol. 2022. PMID: 35762972 No abstract available.
36 results